SDC1 and Miyoshi myopathy: Our studies further demonstrated decreased effector CD4+ Th cells, increased Treg and G-type MDSC, as well as upregulation of immune checkpoints on both effector/regulatory cells and patients CD138+ tumor cells in MM, compared to patients with MGUS and SMM or healthy individuals.